Active Implantable Medical Devices Market by Product (Implantable Cardioverter Defibrillators (Transvenous & Subcutaneous), Cardiac Pacemaker, Ventricular Assist Device, Neurostimulator, Implantable Hearing Devices) - Global Forecast to 2022

Thursday, April 13, 2017 Medical Gadgets
Email Print This Page Comment bookmark
Font : A-A+

LONDON, April 12, 2017 /PRNewswire/ -- The active implantable medical devices market is estimated to grow at a CAGR of 7.8% from 2017 to 2022, to reach USD 26.75 billion by 2022 from USD 18.42 billion in 2017.

The growth of this market is mainly attributed to the rising aging population, increasing prevalence of cardiovascular and neurological diseases, investments and funds to develop technologically advanced products, expanded applications of neurostimulators,
and favorable reimbursement scenario for ENT procedures in developed countries. Download the full report: https://www.reportbuyer.com/product/4823018/However, unfavorable healthcare reforms in the U.S., issues related to the use of implantable medical devices, and the high cost of cardiac and neurostimulators implantable devices may hinder the growth of this market to a certain extent during the forecast period. Growth opportunities in the emerging markets and the development of subcutaneous implantable cardioverter defibrillators offer significant growth opportunities in this market. In this report, the active implantable medical devices market is segmented on the basis of product and region. On the basis of product, the market is segmented into implantable cardioverter defibrillators, implantable cardiac pacemakers, implantable heart monitors/insertable loop recorders, ventricular assist devices, neurostimulators, and implantable hearing devices. The Implantable hearing devices segment is expected to grow at the highest CAGR during the forecast period. The growth of this segment is primarily attributed to the increasing prevalence of hearing loss across the globe and growing ENT procedures due to favorable reimbursement policies in the developed countries. Geographically, North America commanded a major share of the active implantable medical devices market in 2016. Factors such as growth in geriatric population, increasing prevalence of cardiovascular and neurological diseases, high accessibility to advanced technologies, increasing development of innovative and technologically advanced products, and increasing healthcare expenditure in the region are contributing to the large share of North America. However, Asia-Pacific is expected to witness the highest growth rate during the forecast period. Growth in the Asia-Pacific market can be attributed to the rising geriatric population, growing incidence of chronic diseases, rising healthcare spending, healthcare reforms for infrastructural development, growing demand for advanced technologies to develop advanced products, and less stringent regulations in this region. Some of the prominent players in the implantable cardiovascular devices market include Medtronic plc (Ireland), Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), and LivaNova PLC (U.K.); whereas, Cochlear Limited (Australia), MED-EL (Austria), Sonova Holding AG (Switzerland), William Demant Holding A/S (Denmark), and Nurotron Biotechnology Co., Ltd. (China) are the key players in the implantable hearing devices market. Research Coverage: The report analyzes the various type of active implantable medical devices provided by medical device manufacturers across the globe. It aims at estimating the market size and future growth potential of the active implantable medical devices market for different products and regions. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product portfolio, recent developments, and key market strategies. Reasons to Buy the Report: The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for increasing their market shares. The report provides insights on the following pointers: - Market Penetration: Comprehensive information on the product portfolios offered by the top players in the active implantable medical devices market. The report analyzes the active implantable medical devices market by product and region - Product Development/Innovation: Detailed insights on the upcoming trends, research and development activities, and new product launches in the active implantable medical devices market - Market Development: Comprehensive information about the lucrative emerging markets by product and region - Market Diversification: Exhaustive information about new products, growing geographies, recent developments, and investments in the active implantable medical devices market - Competitive Assessment: In-depth assessment of market shares, growth strategies, products, and manufacturing capabilities of leading players in the active implantable medical devices market Download the full report: https://www.reportbuyer.com/product/4823018/About ReportbuyerReportbuyer is a leading industry intelligence solution that provides all market research reports from top publishershttp://www.reportbuyer.comFor more information: Sarah Smith Research Advisor at Reportbuyer.com Email: [email protected] Tel: +44 208 816 85 48 Website: www.reportbuyer.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/active-implantable-medical-devices-market-by-product-implantable-cardioverter-defibrillators-transvenous--subcutaneous-cardiac-pacemaker-ventricular-assist-device-neurostimulator-implantable-hearing-devices---global-forec-300439006.html

SOURCE ReportBuyer



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Find a Doctor
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook